Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells

Kyu‐Tae Kim; Hye Won Lee; Hae‐Ock Lee; Sang Cheol Kim; Yun Jee Seo; Woosung Chung; Hye Hyeon Eum; Do‐Hyun Nam; Junhyong Kim; Kyeung Min Joo; Woong‐Yang Park

doi:10.1186/s13059-015-0692-3

Keywords

BiologyHuman geneticsAdenocarcinomaLung cancerComputational biologyGeneticsDrugCellGenome BiologyCancerCancer researchGenomicsGeneGenomeOncologyPharmacology

Affiliated Institutions

Related Publications

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Naiyer A. Rizvi , Matthew D. Hellmann , Alexandra Snyder +21 more

Immune checkpoint inhibitors, which unleash a patient’s own T cells to kill tumors, are revolutionizing cancer treatment. To unravel the genomic determinants of response to this...

2015 Science 7740 citations

Comprehensive molecular profiling of lung adenocarcinoma

The Cancer Genome Atlas Research Network

Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report molecular profiling of 230 resected lung adenocarcinomas using messenger RNA, microRNA ...

2014 Nature 5605 citations

Exomics and immunogenics

Stéphane Champiat , Charles Ferté , Sophie Lebel‐Binay +2 more

Anti-PD-1/PD-L1 antibodies are emerging as promising anticancer therapeutics. Interestingly, elevated response rates to these agents are mostly documented among patients with tu...

2014 OncoImmunology 187 citations

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

Timothy A. Chan , Mark Yarchoan , Elizabeth M. Jaffee +4 more

Abstract Background Treatment with immune checkpoint blockade (ICB) with agents such as anti-programmed cell death protein 1 (PD-1), anti-programmed death-ligand 1 (PD-L1), and/...

2018 Annals of Oncology 2769 citations

Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

Hira Rizvi , Francisco Sánchez-Vega , Konnor La +29 more

Purpose Treatment of advanced non–small-cell lung cancer with immune checkpoint inhibitors (ICIs) is characterized by durable responses and improved survival in a subset of pati...

2018 Journal of Clinical Oncology 1371 citations

Publication Info

Year: 2015
Type: article
Volume: 16
Issue: 1
Pages: 127-127
Citations: 281
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

281

OpenAlex

Cite This

APA Style

                            
                                
                                    Kyu‐Tae Kim, 
                                
                                    Hye Won Lee, 
                                
                                    Hae‐Ock Lee
                                
                                et al.
                            
                            (2015). 
                            Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells. 
                            Genome Biology
                            , 16
                            (1)
                            , 127-127.
                            https://doi.org/10.1186/s13059-015-0692-3
                        

Identifiers

DOI: 10.1186/s13059-015-0692-3